Terms: = Lung cancer AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616 AND Prognosis
59 results:
1. [Clinical characteristics and prognosis analysis of 17 cases of smarca4-deficient chest tumors].
Cao XN; Li Z; Wang QY
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Apr; 47(4):325-331. PubMed ID: 38599807
[No Abstract] [Full Text] [Related]
2. Thoracic smarca4-deficient tumors: a clinicopathological analysis of 52 cases with smarca4-deficient non-small cell lung cancer and 20 cases with thoracic smarca4-deficient undifferentiated tumor.
Zhou P; Fu Y; Tang Y; Jiang L; Wang W
PeerJ; 2024; 12():e16923. PubMed ID: 38374950
[TBL] [Abstract] [Full Text] [Related]
3. [Cytopathological characteristics of smarca4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
4. Thoracic smarca4-deficient undifferentiated tumor: current knowledge and future perspectives.
Shinno Y; Ohe Y;
Jpn J Clin Oncol; 2024 Mar; 54(3):265-270. PubMed ID: 38117955
[TBL] [Abstract] [Full Text] [Related]
5. [Evaluation of Efficacy and prognosis Analysis of Stage III-IV smarca4-deficient
Non-small Cell lung cancer Treated by PD-1 Immune Checkpoint Inhibitors plus
Chemotherapy and Chemotherapy].
Wang X; Tu M; Jia H; Liu H; Wang Y; Wang Y; Jiang N; Lu C; Zhang G
Zhongguo Fei Ai Za Zhi; 2023 Sep; 26(9):659-668. PubMed ID: 37985152
[TBL] [Abstract] [Full Text] [Related]
6. Diagnosis and management of gastrointestinal smarca4-deficient undifferentiated tumors.
Wang J; Elghawy O; Kurpiel B; Kaur V
Clin J Gastroenterol; 2023 Dec; 16(6):807-814. PubMed ID: 37651059
[TBL] [Abstract] [Full Text] [Related]
7. The clinicopathological features of brg1-deficient non-small cell lung cancer and its response to immunotherapy: A single-center retrospective study.
Zhang J; Zhao R; Xu H; Dong L; Chen X
Ann Diagn Pathol; 2023 Dec; 67():152192. PubMed ID: 37639838
[TBL] [Abstract] [Full Text] [Related]
8. [Clinicopathological features and prognosis of smarca4-deficient non-small cell lung carcinoma: an analysis of 127 cases].
Li SL; Wu CY; Zhang LP; Huang Y; Wu W; Zhang W; Hou LK
Zhonghua Bing Li Xue Za Zhi; 2023 Jul; 52(7):665-670. PubMed ID: 37408395
[No Abstract] [Full Text] [Related]
9. smarca4 as a support for the differential diagnosis of poorly differentiated lung carcinomas.
Panozzi M; Alì G; Proietti A; Melfi F; Zirafa CC; Lucchi M; Fontanini G
Pathologica; 2023 Jun; 115(3):164-171. PubMed ID: 37387441
[TBL] [Abstract] [Full Text] [Related]
10. Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on cancer Therapies including Immunotherapy.
Shi Y; Shin DS
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371564
[TBL] [Abstract] [Full Text] [Related]
11. Chemotherapy and Immune Checkpoint Inhibitors in a Case of smarca4-dUT: A Case Report and Review of Literature.
Pokhrel A; Yadav R; Manvar KK; Wu R; Jaswani V; Wasserman CB; Wang JC
J Investig Med High Impact Case Rep; 2023; 11():23247096231176220. PubMed ID: 37269109
[TBL] [Abstract] [Full Text] [Related]
12. Clinical characteristics and prognostic analysis of smarca4-deficient non-small cell lung cancer.
Liang X; Gao X; Wang F; Li S; Zhou Y; Guo P; Meng Y; Lu T
Cancer Med; 2023 Jul; 12(13):14171-14182. PubMed ID: 37184108
[TBL] [Abstract] [Full Text] [Related]
13. [Thoracic smarca4-deficient undifferentiated tumor resembling malignant lymphoma].
Asou C; Maeda T; Yamaguchi O; Okamura D; Ishikawa M; Kohri M; Tsukasaki K; Matsuda A; Asou N; Satoh T; Kayano H; Takahashi N
Rinsho Ketsueki; 2023; 64(4):271-276. PubMed ID: 37121771
[TBL] [Abstract] [Full Text] [Related]
14. Mutant-allele dispersion correlates with prognosis risk in patients with advanced non-small cell lung cancer.
Wang CX; Yan J; Lin S; Ding Y; Qin YR
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8545-8555. PubMed ID: 37093348
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic Value and Genome Signature of m6A/m5C Regulated Genes in Early-Stage lung Adenocarcinoma.
Tian L; Wang Y; Tian J; Song W; Li L; Che G
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047493
[TBL] [Abstract] [Full Text] [Related]
16. [Thoracic
Xiong Y; Zhang B; Nie LG; Wu SK; Zhao H; Li D; DI JT
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):351-356. PubMed ID: 37042149
[TBL] [Abstract] [Full Text] [Related]
17. Thoracic smarca4-deficient undifferentiated tumor diagnosed by transbronchial mediastinal cryobiopsy: A case report.
Takemura C; Imabayashi T; Furuse H; Uchimura K; Matsumoto Y; Tsuchida T; Watanabe SI
Thorac Cancer; 2023 Apr; 14(10):953-957. PubMed ID: 36828806
[TBL] [Abstract] [Full Text] [Related]
18. smarca4: Current status and future perspectives in non-small-cell lung cancer.
Tian Y; Xu L; Li X; Li H; Zhao M
Cancer Lett; 2023 Feb; 554():216022. PubMed ID: 36450331
[TBL] [Abstract] [Full Text] [Related]
19. TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with smarca4 and regulating its targets
Zhou C; Wang D; Li J; Wang Q; Wo L; Zhang X; Hu Z; Wang Z; Zhan M; He M; Hu G; Chen X; Shen K; Chen GQ; Zhao Q
Proc Natl Acad Sci U S A; 2022 Sep; 119(39):e2117988119. PubMed ID: 36126099
[TBL] [Abstract] [Full Text] [Related]
20. Primary cutaneous smarca4-deficient undifferentiated malignant neoplasm: first two cases with clinicopathologic and molecular comparison to eight visceral counterparts.
Russell-Goldman E; MacConaill L; Hanna J
Mod Pathol; 2022 Dec; 35(12):1821-1828. PubMed ID: 36085356
[TBL] [Abstract] [Full Text] [Related]
[Next]
